Dupixent Lymphoma Lawsuit

People are suing because they believe using Dupixent led them to get a rare skin cancer called cutaneous T-cell lymphoma (CTCL). Some people believe it made the condition appear sooner or get worse. 

Lawsuits Claim Dupixent May Be Linked to Cutaneous T-Cell Lymphoma 

The Dupixent t-cell lymphoma lawsuits say that Dupixent might be connected to a rare cancer called cutaneous T-cell lymphoma (CTCL). People who have filed lawsuits are arguing that the drug might actually cause cancer. Some are also saying it speeds up the cancer’s progression or makes it worse.

There are some scientific studies that show people who took Dupixent had a higher chance of developing CTCL than those who didn’t take the medicine.

But, researchers say these studies simply saw a pattern. There is still no proof that using Dupixent actually causes cancer. Here is what some of the studies say:

• Some research studies have looked at people who developed cutaneous T-cell lymphoma (CTCL) after Dupixent. Scientists have suggested that Dupixent might cause hidden CTCL to appear or make it worse, but so far causation has not been proven.

• A 2024 research study found that eczema patients who took Dupixent had a higher chance of getting CTCL than those who didn’t take it. But that doesn’t prove Dupixent was the cause and scientists say the results could be affected by mix-ups or missing information.

• Another study looked at real records of reports sent by doctors to the FDA, tracking people who said they got CTCL after using Dupixent. They found many more CTCL reports for Dupixent than they did for other medicines. But scientists say these reports aren’t enough to show the true cause, as the information isn’t always complete or fully reliable.

Lawsuits Claim Sanofi and Regeneron Failed to Warn About CTCL Risk

Sanofi and Regeneron are the two companies that make Dupixent. The lawsuits also claim that they did not warn doctors and patients about the serious dangers and risks. Some patients say they did not have enough information to make a decision about the drug. If they had known more, maybe they wouldn’t have taken it. 

Cutaneous T-cell lymphoma is a rare cancer that mostly affects the skin. It starts in special white blood cells called T cells. Normally, T cells help your body fight off sickness, but in CTCL, the T cells stop working right and build up in the skin instead of doing their job.

CTCL Is a Rare Type of Non-Hodgkin Lymphoma

CTCL isn’t like regular skin cancer. It’s a kind of non-Hodgkin lymphoma, which means it acts more like a blood or immune system cancer. Though it usually shows up on your skin, it can also spread to your blood, lymph nodes, or other body parts.

Why CTCL Can Be Mistaken for Eczema

When CTCL first starts, it often looks a lot like common skin problems. Common symptoms include itchy, red, scaly, thick patches on the skin. That’s why many people and their doctors end up thinking it’s just eczema. This confusion means that doctors don’t diagnose the problem quickly, which means treatment is delayed as well.

Mycosis Fungoides and Sézary Syndrome

Mycosis fungoides is the most common type of CTCL. Most people with CTCL actually have this type. It often causes patches or bumps on the skin. Sézary syndrome is a more serious and aggressive type, which isn’t limited just to the skin. In Sézary syndrome, the abnormal T cells can also be found in the blood. This causes more health problems across the whole body. While these two conditions are related (both are CTCL), they are not exactly the same.

Dupixent is a prescription medicine that’s approved by the FDA. People with skin problems like eczema are usually given it as a shot. It can also help with severe asthma, some nose problems with polyps, and eosinophilic esophagitis.

People who have sued Dupixent say that it might change how cutaneous T-cell lymphoma (CTCL) shows up. It could also change how quickly the sickness spreads or whether or not doctors notice it.

Dupixent May Mask, Accelerate, or Worsen CTCL in Some Patients

Some patients say they used Dupixent and felt better at first. However, they were later told that they actually had CTCL instead of eczema. There are claims that Dupixent could possibly hide the lymphoma, bring it out sooner, or cause CTCL to get worse in some individuals.

Scientists have not proven that Dupixent by itself causes cancer. These are claims, not final answers, and each patient’s case can look different. 

Initial Skin Improvement Followed by Worsening Symptoms

Many Dupixent CTCL lawsuits state that people saw itchy skin and rashes get better after Dupixent.

This led doctors to believe the problem was eczema or another minor skin condition. After some time, the person would get new skin patches or more severe spreading and rashes. Then they would eventually find out through medical tests that it was actually CTCL. 

If you’re taking Dupixent and notice any changes in your skin or health that worry you, talk to your doctor right away. Consult your doctor before stopping or changing your medication. But, don’t delay in seeing your doctor and don’t just assume you have eczema. If you notice the following, see your doctor promptly.

Persistent or Worsening Skin Symptoms

Pay attention if you have a skin rash that won’t go away, hard or scaly patches, thickened skin, open sores, or red areas covering large parts of your body. If your symptoms come back, change suddenly, or just don’t get better even as you follow your treatment plan, you should discuss this with your healthcare provider.

Swollen Lymph Nodes or Symptoms That Do Not Behave Like Typical Eczema

You should always tell your doctor if you notice swollen lymph nodes. These often occur in your neck, armpit, or groin, and don’t go away. Some other possible signs that you have more than eczema include being really tired, having a fever, or experiencing night sweats. 

Also, if your rash changes or spreads a lot, or looks different from regular eczema, talk to a doctor. 

Not everyone who took Dupixent will qualify for a lawsuit. Your case will depend on your medical records and when you were diagnosed. It will also depend on your specific diagnosis and how much proof you have of when you used Dupixent.

A lawyer can review your case. Meeting the criteria does not guarantee you have a case, but it gives you a better idea of your options.

Even if you were diagnosed with CTCL and used Dupixent, you still need to present evidence to prove your case. There are important types of evidence that can help you seek compensation by showing your medication timeline, diagnosis, symptom progression, and potential damages.

Dupixent Prescription, Pharmacy, and Medical Records

Get copies of all your medical records from every doctor you saw. Ask your pharmacy for a list of your Dupixent prescriptions too. This way, you can prove you used Dupixent and show exactly when you took it.

Dermatology Records, Biopsy Results, and CTCL Diagnosis Records

If you have records from dermatologists or pathologists, this is also helpful. Biopsies are generally done to determine that you have CTCL, so these results will be needed. Any notes from your oncologist or other treating doctors should be collected as well. 

Timeline of Symptoms Before, During, and After Dupixent

Medical records are important, but your lived experience is, too. Write down a timeline of your symptoms. When did they start? What did you first notice, and when did you first go to the doctor?

Make note of how the symptoms changed over time and what treatment you received. Include anything about your personal experience with the diagnosis and condition.

If you’re considering whether you have a Dupixent lawsuit or not, it’s helpful to understand where these cases stand currently. Dupixent lawsuits from people who used Dupixent and were later diagnosed with CTCL are being reviewed and filed in court.

These Dupixent lawsuits in 2026 claim that Dupixent may have caused or made lymphoma worse, but the courts haven’t reached a verdict and there is no promise of any result. New lawsuits can still be filed while this legal battle moves forward.

Are Dupixent Lawsuits Class Actions?

No, these are not class actions. Each lawsuit is usually brought by the person or family affected by Dupixent and lymphoma. All cases remain separate even though they are about the same topic. Your case is decided based on what happened to you, not a huge class of people.

What an MDL Means for Individual Plaintiffs 

MDL stands for “multidistrict litigation.” This is when many similar lawsuits from different people are put together in one court and before one judge. It helps the cases move faster and allows the judge to make certain decisions about each complaint. 

The cases are not combined, though. Every person still has their own lawsuit and might get a different result or settlement depending on their specific situation.

Why Lawsuits Are Still in the Early Stages

At the moment, lawsuits are still very early on in the process. Medical records, claims, and other evidence are being reviewed. Discovery is ongoing, and there isn’t currently a settlement timeline. 

The primary purpose of filing a lawsuit is to seek compensation from the defendants so you can focus on recovering. The exact compensation you can get depends on your case, but could include what’s known as economic and non-economic damages.  

Medical Bills, Cancer Treatment Costs, and Lost Income

Some of the compensation you could receive is for medical expenses. This includes treatment, oncology care, surgery and prescriptions. You could also get money for not working (both now and in the future) and any out-of-pocket expenses which are directly related to your diagnosis and treatment.

Pain, Suffering, Reduced Quality of Life, and Wrongful Death Damages

These are considered non-economic damages. You may be compensated for the emotional pain and psychological impact of the diagnosis.

You could claim damages for physical pain and suffering, emotional distress, the impact the condition has on your family, and wrongful death damages if applicable.

If you were diagnosed with CTCL after using Dupixent, there are certain steps you should take. These steps help you get the medical care you need but also the legal assistance. 

Talk to Your Doctor Before Making Medication Decisions

Tell your doctor about what you are experiencing and that you think it might be related to taking Dupixent. But you shouldn’t stop taking medications without speaking with your doctor first. Always follow your doctor’s medical advice.

Preserve Your Medical Records and Dupixent Timeline

Gather all of your medical records from every healthcare provider you have seen. Getting copies of your pharmacy records is also a good idea. It gives you proof that Dupixent was prescribed, as well as a timeline of when you took the medication.

Make sure you get any test results, like from biopsies or surgeries. 

Speak With a Dupixent Lymphoma Lawsuit Lawyer

If you are dealing with CTCL, speaking with a lawyer is one of the most important steps you can take. They can review your medical records and let you know if they think you have a valid lawsuit. They’ll look at all deadlines and help ensure your case is filed on time as well.

If you or a loved one was diagnosed with CTCL after using Dupixent, you can request a free case review to find out if you may have a potential claim. Having your medical records, diagnosis date, and Dupixent usage timeline available may help an attorney review your situation.

There is no cost or obligation for this review. If you want to see if your case might qualify, reach out today and speak with someone experienced with Dupixent lawsuits.